Skip to main content
. 2024 Jul 4;14(7):797. doi: 10.3390/biom14070797

Figure 11.

Figure 11

Baicalein, a non-covalent SARS-CoV-2 Mpro inhibitor, and examples of its related compounds (maximum common substructure (MCS)) with known Mpro inhibitory activity. The low potency criterion was IC50 or Ki > 10 μM or Inh% < 75%.